We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Need for specialized concepts and terminology to obtain necessary precision
- Relative rarity of most pediatric conditions
- Outcome measures: General
- Patient-reported outcomes
- Confounding factors on outcomes
- Extrapolation
- Important principles related to extrapolation
- EMA extrapolation
- FDA pediatric extrapolation
- ICH extrapolation guidance
- Extrapolation may not be appropriate if the
- Favorable scenarios for efficacy extrapolation
- Favorable scenarios for efficacy extrapolation: Similarity in drug pharmacology & response
- Favorable scenarios for efficacy extrapolation: Exposure-response relationship is predictable
- Favorable scenarios for safety extrapolation
- Additional favorable scenarios for safety extrapolation
- Study designs for extrapolation
- Further study designs for extrapolation
- Current status and future of pediatric extrapolation
- Consensus scientific and regulatory principles
- Financial disclosures
Topics Covered
- Need for specialized concepts and terminology
- Relative rarity of most pediatric conditions
- Outcome measures: General
- Patient-reported outcomes
- Confounding factors on outcomes
- Important principles related to extrapolation
- EMA extrapolation
- FDA pediatric extrapolation
- ICH extrapolation guidance
- Favorable scenarios for efficacy extrapolation
Links
Categories:
External Links
Talk Citation
Hirschfeld, S. (2026, May 28). Pediatric research: technical & logistical considerations - study design and extrapolation [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved May 29, 2026, from https://doi.org/10.69645/QJCX2611.Export Citation (RIS)
Publication History
- Published on May 28, 2026
Financial Disclosures
- There are no commercial/financial matters to disclose.
Pediatric research: technical & logistical considerations - study design and extrapolation
Published on May 28, 2026
20 min
A selection of talks on Methods
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, this is Prof.
Steven Hirschfeld of
the Uniformed Services
University of
the Health Sciences in
Bethesda, Maryland.
This is Part 3 of a
three-part series on
pediatric research technical
and logistical considerations
and we'll discuss study
design and extrapolation.
0:21
I'll begin by
noting the need for
specialized concepts
and terminology
to obtain the
necessary precision.
As in Part 2, we discussed
that the diseases
can vary based on
chronological age
and developmental stage and
that diseases that are
seen across many ages,
including adult diseases,
can manifest differently
in children.
The concepts and
terminology can be found in
several locations and
I reference too here,
the Clinical Data Interchange
Standards Consortium,
which has a pediatric working
group with terminology
and the very comprehensive
and well-organized
National Cancer Institute
Enterprise Vocabulary Services
are both major
resources to assist in
the proper construction of
pediatric research studies.
1:17
Pediatric conditions in general
are relatively rare in that
they meet the European
Medicines Agency or
the Food and Drug Administration's
definition of rare disease.
A few pediatric diseases
are exceptions.
These are typically infections,
allergic conditions,
inflammatory conditions,
and they can affect hundreds of
thousands to millions
of children.
Many of these diseases
are preventable
through vaccination.
There are also some
chronic diseases
which are increasing in
prevalence, such as asthma,
obesity, attention deficit
hyperactivity disorder,
and type 1 diabetes mellitus.
However, it is important to
examine the epidemiology,
incidence and prevalence
of any pediatric disease
with the expectation that most
will qualify as orphan diseases.